Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

Jul 14, 2020, 16:30 ET 4Front Announces First Quarter 2020 Results and Business Update

Q1 2020 Systemwide Pro Forma Sales of $23.7m, an increase of 36% over Q4 2019. Robust consumer demand continues across all operating markets despite...


Jul 14, 2020, 08:00 ET DUPIXENT® (dupilumab) receives positive recommendation from INESSS for the treatment of moderate-to-severe atopic dermatitis in adolescents

The Institut national d'excellence en santé et en services sociaux (INESSS) recommends extending existing coverage in Quebec to include patients aged ...


Jul 14, 2020, 07:30 ET Mydecine Innovations Group Inc. Signs Definitive Agreement for Acquisition of NeuroPharm Inc.

Mydecine Innovations Group Inc. (CSE: MYCO) (OTC: MYCOF) (FSE:0NF) ("Mydecine" or the "Company"), is pleased to announce that, further to its press...


Jul 14, 2020, 06:00 ET Invivoscribe Launches New Division for Drug Development. Licenses Small Molecule Inhibitors from Domainex to Treat Acute Myeloid Leukemia

Invivoscribe, Inc., an industry pioneer and global leader in the field of precision diagnostics announces the launch of a fully integrated drug...


Jul 14, 2020, 00:30 ET Mydecine Innovations Group Inc. Signs Definitive Agreement for Acquisition of NeuroPharm Inc. Positioned as a Leader in the Development of Psychedelic Treatments for the Betterment of Veterans

Mydecine Innovations Group Inc. (CSE: MYCO) (OTC: MYCOF) (FSE:0NF) ("Mydecine" or the "Company"), is pleased to announce that, further to its press...


Jul 13, 2020, 10:40 ET Valeo Pharma Receives Approval from Health Canada for the Transfer of Commercial Rights to Ametop™

AmetopTM commercialization to begin in July 2020 First of four Valeo products scheduled for launch this summer MONTREAL, July 13, 2020 /CNW Telbec/ - ...


Jul 13, 2020, 08:30 ET Menarini Silicon Biosystems Partners with OpGen to Broaden Distribution of CELLSEARCH Platform in North America

Menarini Silicon Biosystems (MSB), the pioneer of liquid biopsy and rare cell technologies, announced today that it has entered into a strategic...


Jul 13, 2020, 07:55 ET PocketPills Launches in Nova Scotia - Providing Online Pharmacy Access to Medication to All Atlantic Provinces

SURREY, BC, July 13, 2020 /CNW/ - PocketPills, Canada's first full service online pharmacy that delivers pre-sorted medications directly to patients, ...


Jul 13, 2020, 07:30 ET 4Front Announces Fiscal First Quarter 2020 Earnings Date and Conference Call

PHOENIX, Ariz., July 13, 2020 /CNW/ - 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) ("4Front" or the "Company") today announces it plans to issue...


Jul 13, 2020, 07:00 ET The Valens Company Announces Participation in First-of-its-Kind Real-World Evidence Study on Medical Cannabis Led by the University Health Network in Partnership with Shoppers Drug Mart

KELOWNA, BC, July 13, 2020 /CNW/ - The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the "Company" or "The Valens Company"), a global leader in the ...


Jul 13, 2020, 04:00 ET PQE Group Creates an Internal Research Task Force to Fight Fake News in Relation to COVID-19

With the pandemic caused by COVID-19, the continuous need to obtain information has pushed people to rely on unreliable sources, thus fomenting the...


Jul 13, 2020, 03:00 ET SINOMED® Completes One-Year Follow-Up of the PIONEER-III European, US and Japanese Trial of the BuMA Supreme® Coronary Drug-Eluting Stent

SINOMED, a developer of innovative neuro- and cardiovascular technologies, announced the completion of the 1-year follow-up in the PIONEER-III,...


Jul 10, 2020, 15:43 ET Valeo Pharma Closes $1.7 Million Oversubscribed Private Placement

Proceeds to be used to support the summer launch of four products MONTREAL, July 10, 2020 /CNW Telbec/ - Valeo Pharma Inc. (CSE: VPH) ("Valeo" or the ...


Jul 10, 2020, 08:35 ET Cannabis & CBD Biopharma Investor Presentations Now Available for On-Demand Viewing

Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view presentations NEW YORK,...


Jul 10, 2020, 01:00 ET MilliporeSigma Opens its Largest M Lab™ Collaboration Center in Shanghai

MilliporeSigma today opened its M Lab™ Collaboration Center in Shanghai, the company's largest of nine centers worldwide. "With the booming...


Jul 09, 2020, 12:13 ET 4Front Ventures and Massachusetts Cannabis Control Commission Reach Agreement

Settlement Clears Way for Company to Seek Final Adult-Use Licensure PHOENIX, Ariz., July 9, 2020 /CNW/ - 4Front Ventures Corp. (CSE: FFNT) (OTCQX:...


Jul 09, 2020, 09:38 ET MagicMed Industries Files First Psychedelic Derivative Patent

CALGARY, AB, July 9, 2020 /CNW/ - MagicMed Industries Inc. ("MagicMed" or "the Company") today announced that it has filed a provisional patent...


Jul 09, 2020, 09:12 ET Laboratory Studies Confirm BETADINE(R) Antiseptic Products' Effectiveness Against COVID-19 Virus

Mundipharma today announced that laboratory testing at the Duke-NUS Medical School in Singapore, has confirmed the effectiveness of its BETADINE®...


Jul 09, 2020, 08:00 ET Chemistree Closes First Tranche Of Immunoflex Investment

VANCOUVER, BC, July 9, 2020 /CNW/ - Chemistree Technology Inc. (CSE: CHM) and (CSE: CHM.wt) (US OTCQB: CHMJF) (the "Company" or "Chemistree") is...


Jul 09, 2020, 07:30 ET Tris Pharma and KYE Pharmaceuticals Announce Exclusive License Agreement to Commercialize Tris ADHD Products in Canada

Tris Pharma, Inc. ("Tris"), a specialty pharmaceutical company with a robust portfolio of FDA-approved products for the treatment of Attention...


Jul 08, 2020, 07:15 ET SARCLISA™ (isatuximab for injection) now available in Canada for patients with relapsed and refractory multiple myeloma

First and only anti-CD38 antibody in combination with pomalidomide and dexamethasone (pom-dex) to be approved in Canada1,2 SARCLISA™ in combination...


Jul 07, 2020, 13:20 ET Mitsubishi Tanabe Pharma Canada Announces that Nova Scotia has Added the Company's Treatment for Amyotrophic Lateral Sclerosis (ALS) to its Provincial Drug Plan Formulary

TORONTO, July 7, 2020 /CNW/ - Mitsubishi Tanabe Pharma Canada, Inc. (MTP-CA), a subsidiary of Mitsubishi Tanabe Pharma America, Inc. (MTPA),...


Jul 07, 2020, 11:00 ET Takeda Canada Announces New OnePath® Patient Support Program

Takeda's new OnePath® patient-centric program provides personalized patient care and support TORONTO, July 7, 2020 /CNW/ - As part of its on-going...


Jul 07, 2020, 10:23 ET GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine

Collaboration combines innovative plant-based and adjuvant technologies to develop and produce a COVID-19 candidate vaccine Phase 1 clinical testing...


Jul 07, 2020, 09:00 ET Cansortium Inc. Reports First Quarter Financial Results; Reiterates Full Year 2020 Outlook

MIAMI, July 7, 2020 /CNW/ - Cansortium Inc. (CSE:TIUM.U) (OTCQB: CNTMF) ("Cansortium" or the "Company"), a vertically-integrated provider of...